RESUMEN

The arene-supported cationic nickel allyl complexes serve as good catalysts for olefin hydrosilylation at room temperature. Detailed mechanistic studies based on experiments and DFT calculations support the novel mechanism, which includes the facile Si-H bond cleavage and Si-C bond formation, assisted by a non-innocent allyl ligand.

RESUMEN

Cystatin SN (CST1) is one of the several salivary cystatins that form tight equimolar complexes with cysteine proteases, such as the cathepsins. High expression of CST1 is correlated with advanced pTNM stage in gastric cancer. However, the functional role of CST1 in tumorigenesis has not been elucidated. In this study, we showed that CST1 was highly expressed in colon tumor tissues, compared with nontumor regions. Increased cell proliferation and invasiveness were observed in HCT116 cell lines stably transfected with CST1 cDNA (HCT116-CST1) but not in CST3-transfected cells. We also demonstrated that CST1-overexpressing cell lines exhibited increased tumor growth as well as metastasis in a xenograft nude mouse model. Interestingly, CST1 interacted with cystatin C (CST3), a potent cathepsin B (CTSB) inhibitor, with a higher affinity than the interaction between CST3 and CTSB in the extracellular space of HCT116 cells. CTSB-mediated cellular invasiveness and proteolytic activities were strongly inhibited by CST3, but in the presence of CST1 CTSB activities recovered significantly. Furthermore, domain mapping of CST1 showed that the disulfide-bonded conformation, or conserved folding, of CST1 is important for its secretion and for the neutralization of CST3 activity. These results suggest that CST1 upregulation might be involved in colorectal tumorigenesis and acts by neutralizing the inhibition of CTSB proteolytic activity by CST3.

Asunto(s)

Catepsina B/metabolismo , Cistatina C/metabolismo , Cistatinas Salivales/metabolismo , Animales , Western Blotting , Catepsina B/genética , Línea Celular , Neoplasias del Colon/metabolismo , Neoplasias del Colon/patología , Cistatina C/genética , Células HCT116 , Humanos , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Desnudos , Microscopía Confocal , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Cistatinas Salivales/genética

RESUMEN

KRM-1648 resistant Mycobacterium tuberculosis strains were identified from a collection of rifampicin-resistant strains. Several strains had novel rpoB gene mutations in codons 512, 529 and 533 of the rpoB gene. The strains with mutations in codons 526 or 531, major mutation sites in rifampicin-resistant M. tuberculosis, were resistant to KRM-1648. Also, the strains with other mutations in the rpoB gene that were initially susceptible to KRM-1648 were prone to developing KRM-1648 resistance after further mutation. Thus, KRM-1648 is unlikely to be useful for the treatment of rifampicin-resistant tuberculosis.

Asunto(s)

ADN Bacteriano/análisis , ARN Polimerasas Dirigidas por ADN/genética , Mycobacterium tuberculosis/efectos de los fármacos , Mycobacterium tuberculosis/genética , Rifampin/farmacología , Rifamicinas/farmacología , Alelos , Secuencia de Bases , ARN Polimerasas Dirigidas por ADN/análisis , Resistencia a Múltiples Medicamentos/genética , Humanos , Pruebas de Sensibilidad Microbiana , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , Sensibilidad y Especificidad , Análisis de Secuencia de ADN

RESUMEN

Immunization of dendritic cells (DC) pulsed with tumor antigen can activate tumor-specific cytotoxic T lymphocytes (CTL) that are responsible for protection and regression. We show here that immunization with bone marrow-derived DC cocultured with tumor cells can induce a protective immunity against challenges to viable tumor cells. In this study, we further investigated the mechanism by which the antitumor activity was induced. Immunization of mice with DC cocultured with murine colon carcinoma. CT-26 cells, augmented CTL activity against the tumor cells. Concomitantly, an increase in natural killer (NK) cell activity was also detected in the same mice. When DC were fixed with paraformaldehyde prior to coculturing with tumor cells, most of the CTL and NK cell activity diminished, indicating that DC are involved in the process of presenting the tumor antigen(s) to CTL. NK cell depletion in vivo produced markedly low tumor-specific CTL activity responsible for tumor prevention. In addition, RT-PCR analysis confirmed the high expression of INF-gamma mRNA in splenocytes after vaccination with DC cocultured with tumors, but low expression in splenocytes from NK-depleted mice. Most importantly, the tumor protective effect rendered to DC by the coculturing with CT-26 cells was not observed in NK-depleted mice, which suggests that DC can induce an antitumor immune response by enhancing NK cell-dependent CTL activation. Collectively, our results indicate that NK cells are required during the priming of cytotoxic T-cell response by DC-based tumor vaccine and seem to delineate a mechanism by which DC vaccine can provide the desired immunity.

Asunto(s)

Vacunas contra el Cáncer/inmunología , Células Dendríticas/inmunología , Células Asesinas Naturales/inmunología , Linfocitos T Citotóxicos/inmunología , Adenocarcinoma/inmunología , Adenocarcinoma/patología , Adenocarcinoma/prevención & control , Adenocarcinoma/terapia , Animales , Presentación de Antígeno , Células de la Médula Ósea/citología , Técnicas de Cocultivo , Neoplasias del Colon/inmunología , Neoplasias del Colon/patología , Neoplasias del Colon/terapia , Citotoxicidad Inmunológica , Células Dendríticas/efectos de los fármacos , Factor Estimulante de Colonias de Granulocitos y Macrófagos/farmacología , Inmunización , Memoria Inmunológica , Interferón gamma/biosíntesis , Interferón gamma/genética , Interleucina-4/farmacología , Neoplasias Renales/patología , Activación de Linfocitos , Depleción Linfocítica , Linfoma/patología , Masculino , Ratones , Ratones Endogámicos BALB C , Trasplante de Neoplasias , ARN Mensajero/biosíntesis , ARN Mensajero/genética , Organismos Libres de Patógenos Específicos , Células Tumorales Cultivadas/inmunología , Vacunación

RESUMEN

1. Interleukin-12 (IL-12) may play a central role in the development and progression of rheumatoid arthritis by driving the immune response towards T helper 1 (Th1) type responses characterized by high IFN-gamma and low IL-4 production. In this study we investigated the effect of auranofin (AF), an anti-rheumatic gold compound, on IL-12 production in mouse macrophages and dendritic cells, and studied whether AF-mediated inhibition of IL-12 production could regulate a cytokine profile of antigen (Ag)-primed CD4(+) Th cells. 2. Treatment with AF significantly inhibited IL-12 production in lipopolysaccharide (LPS)-stimulated macrophages and also in CD40L-stimulated dendritic cells. AF-pretreated macrophages reduced their ability to induce IFN-gamma and increased the ability to induce IL-4 in Ag-primed CD4(+) T cells. AF did not influence the cell surface expression of the class II MHC molecule and the costimulatory molecules CD80 and CD86. 3. Addition of recombinant IL-12 to cultures of AF-pretreated macrophages and CD4(+) T cells restored IFN-gamma production in Ag-primed CD4(+) T cells. 4. The in vivo administration of AF resulted in the inhibition of IL-12 production by macrophages stimulated in vitro with LPS or heat-killed Listeria monocytogenes (HKL), leading to the inhibition of Th1 cytokine profile (decreased IFN-gamma and increased IL-4 production) in Ag-primed CD4(+) T cells. 5. These findings may explain some known effects of AF including anti-rheumatic effects and the inhibition of encephalitogenicity, and point to a possible therapeutic use of AF in the Th1-mediated immune diseases such as autoimmune diseases.

Asunto(s)

Antirreumáticos/farmacología , Auranofina/farmacología , Citocinas/metabolismo , Interleucina-12/antagonistas & inhibidores , Interleucina-12/biosíntesis , Células TH1/efectos de los fármacos , Células Th2/efectos de los fármacos , Animales , Linfocitos T CD4-Positivos/efectos de los fármacos , Linfocitos T CD4-Positivos/metabolismo , Células Cultivadas , Células Dendríticas/efectos de los fármacos , Células Dendríticas/metabolismo , Relación Dosis-Respuesta Inmunológica , Macrófagos/efectos de los fármacos , Macrófagos/metabolismo , Ratones , Ratones Endogámicos DBA , Células TH1/metabolismo , Células Th2/metabolismo

RESUMEN

To understand modulation of a novel immune-related cytokine, interleukin-18, by human papillomavirus type (HPV) 16 oncogenes, HaCaT, normal keratinocyte cell line, and C-33A, HPV-negative cervical cancer cell line, were prepared to establish stable cell lines expressing E6, E6 mutant (E6m), E6E7, or E7 constitutively. Expressions of various HPV oncogene transcripts were identified by RT-PCR. Expression of HPV oncogene E6 was reversely correlated to the expression of interleukin-18, a novel pro-inflammatory cytokine. The expression of E6 in C-33A, independent of E6 splicing, resulted in decreased IL-18 expression and that of IL-18 was also significantly reduced in HaCaT cells expressing E6. The level of p53 was reduced in C-33A cells expressing E6 whereas not altered in HaCaT cells expressing E6, suggesting that E6 downregulated IL-18 expression via an independent pathway of p53 degradation in HaCaT cells which have a mutated p53 form. However, E7 did not affect IL-18 expression significantly in both C-33A and HaCaT cells. Cotransfection experiments showed that E6 oncogene did not inhibit the activities of IL-18 promoter P1 and P2, suggesting that E6 oncogene indirectly inhibited IL-18 expression. Taken together, E6, E6m and E6/E7 inhibited IL-18 expression with some variation, assuming that cells expressing E6 oncogene can evade immune surveillance by downregulating the expression of immune stimulating cytokine gene, IL-18, and inhibiting the cascade of downstream effects that follow activation of the IL-18 receptor.

Asunto(s)

Interleucina-18/metabolismo , Proteínas Oncogénicas Virales/farmacología , Papillomaviridae , Proteínas Represoras , Proteína p53 Supresora de Tumor/metabolismo , Unión Competitiva , Regulación hacia Abajo , Células HeLa/efectos de los fármacos , Células HeLa/metabolismo , Células HeLa/virología , Humanos , Interferón gamma/biosíntesis , Interferón gamma/metabolismo , Interleucina-18/genética , Leucocitos Mononucleares/efectos de los fármacos , Leucocitos Mononucleares/metabolismo , Leucocitos Mononucleares/virología , Proteínas Oncogénicas Virales/genética , Proteínas Oncogénicas Virales/metabolismo , Regiones Promotoras Genéticas/efectos de los fármacos , Transfección , Células Tumorales Cultivadas

RESUMEN

Cervical carcinoma is the predominant cancer among malignancies in women throughout the world, and human papillomavirus (HPV) 16 is the most common agent linked to human cervical carcinoma. The present study was performed to investigate the mechanisms of immune escape in HPV-induced cervical cancer cells. The presence of HPV oncoproteins E6 and E7 in the extracellular fluids of HPV-containing cervical cancer cell lines SiHa and CaSki was demonstrated by ELISA. The effect of HPV 16 oncoproteins E6 and E7 on the production of IFN-gamma by IL-18 was assessed. E6 and E7 proteins reduced IL-18-induced IFN-gamma production in both primary PBMCs and the NK0 cell line. FACS analysis revealed that the viral oncoproteins reduced the binding of IL-18 to its cellular surface receptors on NK0 cells, whereas there was no effect of oncoproteins on IL-1 binding to its surface IL-1 receptors on D10S, a subclone of the murine Th cell D10.G4.1. In vitro pull-down assays also revealed that the viral oncoproteins and IL-18 bound to IL-18R alpha-chain competitively. These results suggest that the extracellular HPV 16 E6 and E7 proteins may inhibit IL-18-induced IFN-gamma production locally in HPV lesions through inhibition of IL-18 binding to its alpha-chain receptor. Down-modulation of IL-18-induced immune responses by HPV oncoproteins may contribute to viral pathogenesis or carcinogenesis.

Asunto(s)

Adyuvantes Inmunológicos/fisiología , Interferón gamma/antagonistas & inhibidores , Interleucina-18/fisiología , Células Asesinas Naturales/inmunología , Leucocitos Mononucleares/inmunología , Proteínas Oncogénicas Virales/fisiología , Papillomaviridae/inmunología , Proteínas Represoras , Adyuvantes Inmunológicos/metabolismo , Unión Competitiva/inmunología , Línea Celular , Sistema Libre de Células/química , Sistema Libre de Células/metabolismo , Células Cultivadas , Humanos , Interferón gamma/biosíntesis , Interleucina-1/metabolismo , Interleucina-18/antagonistas & inhibidores , Interleucina-18/metabolismo , Subunidad alfa del Receptor de Interleucina-18 , Células Asesinas Naturales/metabolismo , Leucocitos Mononucleares/metabolismo , Proteínas Oncogénicas Virales/metabolismo , Proteínas E7 de Papillomavirus , Unión Proteica/inmunología , Receptores de Interleucina/antagonistas & inhibidores , Receptores de Interleucina/metabolismo , Receptores de Interleucina-1/metabolismo , Receptores de Interleucina-18 , Células Tumorales Cultivadas

RESUMEN

The cDNA clones, which were highly expressed in liver tissues of hepatocellular carcinoma (HCC) patients, were identified using dot hybridization and reconfirmed by Northern blot analysis. One of the clones, ninjurin (nerve injury induced protein), showed a much higher expression level in the liver tissue of HCC patients than in normal liver tissue. Interestingly, the presence of ninjurin mRNA transcripts was detected with high intensity in HCC tissues when combined with viral infection and cirrhosis, but not with a normal liver or HCC tissue unrelated with viral infection and cirrhosis. We produced a N-terminal part of recombinant ninjurin protein, as well as a monoclonal antibody specific to this polypeptide. The intensity of immunohistochemical staining of the liver tumor tissue, and regenerating tissue for the ninjurin protein, was stronger than that of normal liver tissue. These results suggest that ninjurin may play an important role in the development of HCC combined with cirrhosis and viral infection.

Asunto(s)

Carcinoma Hepatocelular/metabolismo , Moléculas de Adhesión Celular Neuronal/biosíntesis , Hepatitis Viral Humana/metabolismo , Cirrosis Hepática/metabolismo , Neoplasias Hepáticas/metabolismo , Factores de Crecimiento Nervioso/biosíntesis , Animales , Carcinoma Hepatocelular/complicaciones , Carcinoma Hepatocelular/genética , Moléculas de Adhesión Celular Neuronal/genética , Hepatitis Crónica/complicaciones , Hepatitis Crónica/genética , Hepatitis Crónica/metabolismo , Hepatitis Viral Humana/complicaciones , Hepatitis Viral Humana/genética , Humanos , Immunoblotting , Inmunohistoquímica , Hígado/anatomía & histología , Hígado/patología , Hígado/fisiología , Hígado/fisiopatología , Cirrosis Hepática/complicaciones , Cirrosis Hepática/genética , Neoplasias Hepáticas/complicaciones , Neoplasias Hepáticas/genética , Factores de Crecimiento Nervioso/genética , ARN/metabolismo , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Células Tumorales Cultivadas , Regulación hacia Arriba

RESUMEN

Glucocorticoids (GC) are potent anti-inflammatory and immunosuppressive agents that act on a variety of immune cells, including T cells, monocytes/macrophages, osteoclasts, and dendritic cells (DC). However, the mechanism(s) by which GC exert anti-inflammatory effects is still largely unknown. It is already well known that GC treatment inhibits DC maturation and interleukin (IL)-12 production by DC. In this study, we investigated the apoptosis induction of DC by a synthetic GC, dexamethasone (Dex). The stimulation with Dex resulted in DC apoptosis in a dose- and time-dependent manner as it was measured by determining annexin V-positive cells and mitochondrial potential. In contrast, monocytes that are precursor cells of DC are resistant to Dex-mediated apoptosis. The Dex-induced apoptosis of DC was independent of caspase activation because it was not inhibited by the broad caspase inhibitor, Z-VAD-fmk. It is interesting that agonistic CD40 antibody completely inhibited Dex-induced cell death, whereas other inflammatory stimuli did not show the same effect, suggesting that CD40 signaling may selectively modulate GC-mediated DC apoptosis. Taken together, our findings revealed an important role of GC and CD40 signaling in the regulation of immune responses in which DC play a key role in the inflammatory process of various immunomediated diseases.

Asunto(s)

Apoptosis/fisiología , Antígenos CD40/fisiología , Caspasas/metabolismo , Células Dendríticas/citología , Dexametasona/farmacología , Glucocorticoides/farmacología , Antiinflamatorios/antagonistas & inhibidores , Antiinflamatorios/farmacología , Anticuerpos/inmunología , Anticuerpos/farmacología , Apoptosis/efectos de los fármacos , Apoptosis/genética , Antígenos CD40/inmunología , Inhibidores de Caspasas , Células Dendríticas/efectos de los fármacos , Células Dendríticas/fisiología , Dexametasona/antagonistas & inhibidores , Activación Enzimática , Expresión Génica , Glucocorticoides/antagonistas & inhibidores , Antagonistas de Hormonas/farmacología , Humanos , Mifepristona/farmacología , Receptores de Glucocorticoides/antagonistas & inhibidores , Transducción de Señal/fisiología

RESUMEN

The Mycobacterium bovis bacilli Calmette-Guerin (BCG) pcp gene that encodes the pyrrolidone carboxyl peptidase (Pcp) was cloned from a lambdagtll genomic library and sequenced. The nucleotide sequence contains a 669 bp open reading frame coding for a protein of 222 amino acid residues with a calculated molecular mass of 23,209 Da. The deduced amino acid sequence is highly homologous to the Pcps from Bacillus amyloliquefaciens, Pseudomonas fluorescens, Bacillus subtilis, Streptococcus pyogenes, and Staphylococcus aureus. A multiple sequence alignment revealed highly conserved domains. The BCG pcp gene was overexpressed in Escherichia coli. The Pcp was purified to homogeneity. The recombinant protein was further confirmed by an enzymatic assay.

Asunto(s)

Mycobacterium bovis/genética , Piroglutamil-Peptidasa I/genética , Secuencia de Aminoácidos , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Secuencia de Bases , Clonación Molecular , Datos de Secuencia Molecular , Mycobacterium bovis/enzimología , Estructura Terciaria de Proteína , Piroglutamil-Peptidasa I/metabolismo , Alineación de Secuencia , Análisis de Secuencia de ADN

RESUMEN

The D variant of encephalomyocarditis (EMC-D) virus causes diabetes in susceptible mice by direct cytolysis of pancreatic beta-cells. cDNA covering the major outer capsid protein (VP1) of the EMC-D virus was cloned into Mycobacterium bovis bacillus Calmette-Guerin (BCG). None of the SJL/J mice immunized with live recombinant BCG-VP1 (rBCG-VP1) became diabetic when challenged with the highly diabetogenic EMC-D virus, but the control mice inoculated with normal BCG developed diabetes during the same challenge. VP1-specific antibodies (including neutralizing antibodies) were markedly increased over time and reached the maximum titer at week 10 after a single immunization. The plateau of the titer lasted longer than 4 weeks. Mice and guinea pigs immunized with live rBCG-VP1 showed strong delayed-type hypersensitivity to the VP1 of the EMC-D virus. The preventive immunity still worked effectively 10 months after the primary immunization. At that time, the VP1-specific antibody was almost undetectable in the bloodstream, but a large number of VP1-specific lymphocytes was found in the spleen of the immunized mice. Our results show that live rBCG-VP1 elicits effective humoral and long-lasting cellular immune responses against EMC-D virus infection that results in the prevention of virus-induced diabetes in susceptible mice.

Asunto(s)

Vacuna BCG/uso terapéutico , Proteínas de la Cápside , Cápside/inmunología , Infecciones por Cardiovirus/complicaciones , Diabetes Mellitus Tipo 1/prevención & control , Diabetes Mellitus Tipo 1/virología , Virus de la Encefalomiocarditis , Mycobacterium bovis/inmunología , Vacunas Sintéticas/uso terapéutico , Animales , Secuencia de Bases , Cápside/genética , Clonación Molecular , Virus de la Encefalomiocarditis/genética , Virus de la Encefalomiocarditis/inmunología , Genoma Viral , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos , Mycobacterium bovis/genética , Proteínas Recombinantes/genética , Proteínas Recombinantes/inmunología

RESUMEN

Interleukin-12 (IL-12) plays a central role in the immune system by driving the immune response towards T helper 1 (Th1) type responses characterized by high IFN-gamma and low IL-4 production. In this study we investigated whether retinoid-mediated inhibition of interleukin-12 production in mouse macrophages could regulate cytokine profile of antigen (Ag)-primed CD4(+) Th cells. Pretreatment with retinoids (9-cis-RA, all-trans-RA, TTNPB) significantly inhibited IL-12 production by mouse macrophages stimulated with lipopolysaccharide (LPS) or heated-killed Listeria monocytogenes (HKL). Retinoid-pretreated macrophages reduced their ability to induce IFN-gamma and increased the ability to induce IL-4 in Ag-primed CD4(+) T cells. Addition of recombinant IL-12 to cultures of retinoid-pretreated macrophages and CD4(+) T cells restored IFN-gamma production in CD4(+) T cells. The in vivo administration of 9-cis-RA resulted in the inhibition of IL-12 production by macrophages stimulated in vitro with either LPS or HKL, leading to the inhibition of Th1 cytokine profile (decreased IFN-gamma and increased IL-4 production) in CD4(+) T cells. These findings may explain some known effects of retinoids including the inhibition of encephalitogenicity, and point to a possible therapeutic use of retinoids in the Th1-mediated immune diseases such as autoimmune diseases.

Asunto(s)

Linfocitos T CD4-Positivos/metabolismo , Citocinas/sangre , Interleucina-12/biosíntesis , Macrófagos/metabolismo , Retinoides/farmacología , Animales , Antígenos Bacterianos/farmacología , Linfocitos T CD4-Positivos/efectos de los fármacos , Interferón gamma/biosíntesis , Interleucina-12/farmacología , Interleucina-4/biosíntesis , Lipopolisacáridos/farmacología , Listeria monocytogenes/inmunología , Macrófagos/efectos de los fármacos , Ratones , Proteínas Recombinantes/farmacología

RESUMEN

1 Interleukin-12 (IL-12) plays a central role in the immune system by driving the immune response towards T helper 1 (Th1) type responses which are characterized by high IFN-gamma and low IL-4 production. In this study we investigated the effects of curcumin, a natural product of plants obtained from Curcuma longa (turmeric), on IL-12 production by mouse splenic macrophages and the subsequent ability of these cells to regulate cytokine production by CD4+ T cells. 2 Pretreatment with curcumin significantly inhibited IL-12 production by macrophages stimulated with either lipopolysaccharide (LPS) or head-killed Listeria monocytogenes (HKL). 3 Curcumin-pretreated macrophages reduced their ability to induce IFN-gamma and increased the ability to induce IL-4 in Ag-primed CD4+ T cells. Addition of recombinant IL-12 to cultures of curcumin-pretreated macrophages and CD4+ T cells restored IFN-gamma production in CD4+ T cells. 4 The in vivo administration of curcumin resulted in the inhibition of IL-12 production by macrophages stimulated in vitro with either LPS or HKL, leading to the inhibition of Th1 cytokine profile (decreased IFN-gamma and increased IL-4 production) in CD4+ T cells. 5 These findings suggest that curcumin may inhibit Th1 cytokine profile in CD4+ T cells by suppressing IL-12 production in macrophages, and points to a possible therapeutic use of curcumin in the Th1-mediated immune diseases.

Asunto(s)

Antiinflamatorios no Esteroideos/farmacología , Linfocitos T CD4-Positivos/metabolismo , Curcumina/farmacología , Interleucina-12/antagonistas & inhibidores , Interleucina-12/biosíntesis , Macrófagos/metabolismo , Células TH1/metabolismo , Animales , Linfocitos T CD4-Positivos/efectos de los fármacos , Ensayo de Inmunoadsorción Enzimática , Interferón gamma/biosíntesis , Interleucina-4/biosíntesis , Lipopolisacáridos/farmacología , Listeria monocytogenes/inmunología , Macrófagos/efectos de los fármacos , Ratones , Ratones Endogámicos DBA , Células TH1/efectos de los fármacos

RESUMEN

Interleukin-12 (IL-12) plays a pivotal role in the development of T-helper 1 (Th1) immune response, which may be involved in the pathogenesis of chronic inflammatory autoimmune disorders. In this study we investigated the effects of sulfasalazine, a drug for treating inflammatory bowel disease and rheumatoid arthritis, on the production of IL-12 from mouse macrophages stimulated with lipopolysaccharide (LPS). Sulfasalazine potently inhibited the production of IL-12 in a dose-dependent manner, in part through the down-regulation of nuclear factor kappaB (NFkappaB) activation in IL-12 p40 gene. Activation of macrophages by LPS resulted in markedly enhanced binding activities to the kappaB site, which significantly decreased upon addition of sulfasalazine as demonstrated by an electrophoretic gel shift assay. Importantly, macrophages pretreated with sulfasalazine either in vitro or in vivo reduced their ability to induce interferon-gamma (IFN-gamma) and increased the ability to induce IL-4 in antigen-primed CD4+ T cells. From these results, sulfasalazine may induce the Th2 cytokine profile in CD4+ T cells by suppressing IL-12 production in macrophages, and sulfasalazine-induced inhibition of IL-12 production in macrophages may explain some of the known biological effects of sulfasalazine.

Asunto(s)

Antibacterianos/farmacología , Interleucina-12/biosíntesis , Macrófagos/inmunología , Sulfasalazina/farmacología , Células TH1/inmunología , Animales , Linfocitos T CD4-Positivos/inmunología , Células Cultivadas , Femenino , Lipopolisacáridos/farmacología , Listeria monocytogenes/inmunología , Listeriosis/inmunología , Macrófagos/efectos de los fármacos , Ratones , Ratones Endogámicos DBA , Células TH1/efectos de los fármacos

RESUMEN

Dendritic cells (DCs) are potent professional antigen-presenting cells (APC) capable of inducing the primary T cell response to antigen. Although tumor cells express target antigens, they are incapable of stimulating a tumor-specific immune response due to a defect in the costimulatory signal that is required for optimal activation of T cells. In this work, we describe a new approach using tumor-DC coculture to improve the antigen presenting capacity of tumor cells, which does not require a source of tumor-associated antigen. Immunization of a weakly immunogenic and progressive tumor cocultured with bone marrow-derived DCs generated an effective tumor vaccine. Immunization with the cocultured DCs was able to induce complete protective immunity against tumor challenges and was effective for the induction of tumor-specific CTL (cytotoxic T lymphocyte) activity. Furthermore, high NK cell activity was observed in mice in which tumors were rejected. In addition, immunization with tumor-pulsed DCs induced delayed tumor growth, but not tumor eradication in tumor-bearing mice. Our results demonstrate that coculture of DCs with tumors generated antitumor immunity due to the NK cell activation as well as tumor-specific T cell. This approach would be useful for designing tumor vaccines using DCs when the information about tumor antigens is limited.

Asunto(s)

Anticuerpos Antineoplásicos/inmunología , Dendritas/inmunología , Células Asesinas Naturales/inmunología , Activación de Linfocitos/inmunología , Linfocitos T Citotóxicos/inmunología , Animales , Antígenos de Neoplasias/inmunología , Células de la Médula Ósea/inmunología , Células Cultivadas , Técnicas de Cocultivo , Pruebas Inmunológicas de Citotoxicidad , Citometría de Flujo , Indicadores y Reactivos , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Fenotipo , Células Tumorales Cultivadas

RESUMEN

Dendritic cells (DCs) are most potent among the antigen-presenting cells and are believed to be crucial for the initiation of a primary T-cell response to foreign antigens. Mycobacterial infection within macrophages is controlled by cell-mediated immunity. To elucidate the stimulation of immune response by Mycobacterium bovis bacillus Calmette-Guérin (BCG), we purified DCs from precursor cells in human peripheral blood mononuclear cells (PBMC) by culturing them with granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-4 (IL-4) and characterized their surface antigen expression. The interaction of cultured DCs with BCG resulted in increased surface expression of several DC-related marker antigens. BCG also induced reduction of endocytosis, enhancement of CD83 expression as well as B7 costimulatory molecules and IL-12 production, suggesting that BCG treatment directly induces DCs to mature. BCG-treated DCs were much more potent antigen-presenting cells in allogeneic immune response than untreated DCs. Moreover, while the neutralization of tumour necrosis factor-alpha (TNF-alpha) significantly blocked the DC maturation induced by lipopolysaccharide (LPS), it could not inhibit the induction of DC maturation by the BCG treatment, indicating that TNF-alpha production plays a minor role in the BCG-induced DC maturation. However, the neutralization of TNF-alpha resulted in decreased IL-12 production by activated DCs. These results suggest that infection with BCG might evoke direct activation and maturation of DC and the general immune stimulant effect of BCG might be related with the activation of DCs.

Asunto(s)

Presentación de Antígeno/inmunología , Células Dendríticas/inmunología , Mycobacterium bovis/inmunología , Factor de Necrosis Tumoral alfa/inmunología , Antígenos CD/metabolismo , Técnicas de Cultivo de Célula , Diferenciación Celular , Humanos , Inmunoglobulinas/metabolismo , Interleucina-12/biosíntesis , Leucocitos Mononucleares/inmunología , Lipopolisacáridos/inmunología , Activación de Linfocitos/inmunología , Glicoproteínas de Membrana/metabolismo , Linfocitos T/inmunología , Antígeno CD83

RESUMEN

cDNA clones encoding two different subtypes of histone macroH2A1, macroH2A1.1 and macroH2A1.2, have been isolated from human liver tissue. The open reading frames in the isolated clones predicted proteins comprising 368 and 371 amino acids respectively. Estimated molecular masses of the two proteins were 39.0 kDa and 39.4 kDa. Human histone macroH2A1.1 and macroH2A1.2 showed about 98% identity with their counterparts isolated from rat. The features of the nucleotide sequences of the two macroH2A1 subtypes in human were the same as in the rat system. Northern blot analysis showed that the macroH2A1.1 and macroH2A1.2 subtypes were expressed as mRNA species with a size of 1.5 and 4.4 kb, respectively. They were expressed in all human tissues examined.

Asunto(s)

ADN Complementario/aislamiento & purificación , Histonas/genética , Hígado/metabolismo , Secuencia de Aminoácidos , Secuencia de Bases , Sondas de ADN , ADN Complementario/química , Humanos , Datos de Secuencia Molecular , ARN Mensajero/análisis , Alineación de Secuencia

RESUMEN

For the rapid identification of noble genes in a specific tissue by computer analysis from the cDNA sequences determined by single-pass cDNA sequencing, clone redundancy was one of the major obstacles. To facilitate the efficiency in identification of noble genes, it was necessary to reduce the number of clones to be sequenced by eliminating the redundant clones for a rapid analysis. In order to increase the probability of isolating noble sequences from the cDNA clones of human fetal liver tissue origin, colony hybridization assay was adopted and redundant clones were efficiently removed. Four cDNA clones highly redundant in the human fetal liver cDNA libraries including alpha-globin, gamma-globin, serum albumin and H19 RNA sequences were selected as the probes. Two hundreds and sixty two cDNA clones were randomly selected and tested with the probes for hybridization properties. The identity of each cDNA clone giving positive or negative signals in the hybridization assay was determined by DNA homology search with the nucleic acid databases. Among the 76 clones giving positive signals, 57 clones (75%) were found to be identical to the probe sequences and could be eliminated by colony hybridization assay before neucleotide sequencing.

Asunto(s)

Clonación Molecular/métodos , ADN Complementario/genética , Técnicas de Sonda Molecular , Sondas de ADN , Feto , Biblioteca de Genes , Humanos , Hígado , Hibridación de Ácido Nucleico , Análisis de Secuencia de ADN , Homología de Secuencia de Ácido Nucleico

RESUMEN

We have devised a formula for ventilator settings which provide normal minute ventilation without rebreathing during controlled ventilation using a Jackson Rees or Bain system. As VT = VS + VF- VL, where VT = delivered tidal volume, VS = set tidal volume, VF = the volume of fresh gas entering during the inspiratory phase and VL = the lost volume due to the compliance of the system, VS was derived: VS = VL + VT x [1-b/(1 + a)] where a = expiratory-to-inspiratory ratio and b = the ratio of fresh gas flow to the minute ventilation. It was evaluated in 62 infants. Arterial partial pressure of carbon dioxide (mean (SD)) was 4.6 (0.5) kPa (35 (4) mmHg) with a range of 3.42-5.78 kPa (26-44 mmHg). The 90th percentile was 5.1 kPa (39 mmHg). It is concluded that predictable normocapnia [corrected] can be conveniently achieved in infants in controlled ventilation with Jackson Rees or Bain system if our formula is applied.

Asunto(s)

Anestesia por Inhalación/métodos , Dióxido de Carbono/sangre , Respiración Artificial/métodos , Envejecimiento/sangre , Anestesia por Inhalación/instrumentación , Peso Corporal , Estudios de Evaluación como Asunto , Humanos , Lactante , Matemática , Modelos Biológicos , Presión Parcial , Volumen de Ventilación Pulmonar

RESUMEN

The complete nucleotide sequence of a 1,513 bp fragment of Mycobacterium bovis BCG containing the secY gene homolog and partial adk gene that encodes an adenylate kinase has been determined. The secY gene of BCG has an open reading frame of 441 amino acids with homology to the SecY protein family. Comparative analyses of the deduced amino acid sequence of additional partial ORF revealed strong similarity to the known adenylate kinases.

Asunto(s)

Proteínas Bacterianas/genética , Clonación Molecular , Proteínas de Escherichia coli , Mycobacterium bovis/genética , Análisis de Secuencia de ADN , Secuencia de Aminoácidos , Bacillus subtilis/genética , Secuencia de Bases , Escherichia coli/genética , Biblioteca de Genes , Datos de Secuencia Molecular , Canales de Translocación SEC , Homología de Secuencia , Streptococcus/genética